|Articles|July 6, 2016
Hanmi Selects Medidata Cloud Technology
Medidata has signed a multi-year deal with South Koreas Hanmi Pharmaceuticals.
Advertisement
Medidata has signed a multi-year deal with South Korea's Hanmi Pharmaceuticals. The Seoul-based company is adopting Medidatas Clinical Cloud platform into all clinical trials across its drug development programs.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
2
Breaking the Efficacy Ceiling in IBD and Beyond
3
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
4
The Career They Didn't Train For: Rethinking Early-Career Burnout in Clinical Research
5